These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 33656478)

  • 1. Pharmacological Treatment of Agitation and/or Aggression in Patients With Traumatic Brain Injury: A Systematic Review of Reviews.
    Rahmani E; Lemelle TM; Samarbafzadeh E; Kablinger AS
    J Head Trauma Rehabil; 2021 Jul-Aug 01; 36(4):E262-E283. PubMed ID: 33656478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A descriptive analysis of pharmacological management of aggression and/or agitation in patients with traumatic brain injury in a Southwest Virginia inpatient population.
    Rahmani E; Lemelle T; Sharp H; Smarbafzadeh E; Kablinger A
    J Clin Pharm Ther; 2022 Dec; 47(12):2083-2090. PubMed ID: 36543254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological management for agitation and aggression in people with acquired brain injury.
    Fleminger S; Greenwood RJ; Oliver DL
    Cochrane Database Syst Rev; 2006 Oct; (4):CD003299. PubMed ID: 17054165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Care management of the agitation or aggressiveness crisis in patients with TBI. Systematic review of the literature and practice recommendations.
    Luauté J; Plantier D; Wiart L; Tell L;
    Ann Phys Rehabil Med; 2016 Feb; 59(1):58-67. PubMed ID: 26700025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aripiprazole (intramuscular) for psychosis-induced aggression or agitation (rapid tranquillisation).
    Ostinelli EG; Jajawi S; Spyridi S; Sayal K; Jayaram MB
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD008074. PubMed ID: 29308601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation).
    Ostinelli EG; Hussein M; Ahmed U; Rehman FU; Miramontes K; Adams CE
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD009412. PubMed ID: 29634083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological interventions for agitation in patients with traumatic brain injury: protocol for a systematic review and meta-analysis.
    Williamson DR; Frenette AJ; Burry L; Perreault MM; Charbonney E; Lamontagne F; Potvin MJ; Giguère JF; Mehta S; Bernard F
    Syst Rev; 2016 Nov; 5(1):193. PubMed ID: 27855720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological interventions for agitated behaviours in patients with traumatic brain injury: a systematic review.
    Williamson D; Frenette AJ; Burry LD; Perreault M; Charbonney E; Lamontagne F; Potvin MJ; Giguère JF; Mehta S; Bernard F
    BMJ Open; 2019 Jul; 9(7):e029604. PubMed ID: 31289093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological management for agitation and aggression in people with acquired brain injury.
    Fleminger S; Greenwood RJ; Oliver DL
    Cochrane Database Syst Rev; 2003; (1):CD003299. PubMed ID: 12535468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of olanzapine to treat agitation in traumatic brain injury: study protocol for a randomised controlled trial.
    Phyland RK; McKay A; Olver J; Walterfang M; Hopwood M; Hicks AJ; Mortimer D; Ponsford JL
    Trials; 2020 Jul; 21(1):662. PubMed ID: 32690072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.
    Ballard C; Waite J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD003476. PubMed ID: 16437455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Pharmacological Management of Behavioral and Emotional Dysregulation Following a Traumatic Brain Injury: A Systematic Review of the Literature.
    Nash RP; Weinberg MS; Laughon SL; McCall RC; Bateman JR; Rosenstein DL
    Psychosomatics; 2019; 60(2):139-152. PubMed ID: 30665668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement and treatment of agitation following traumatic brain injury: II. A survey of the Brain Injury Special Interest Group of the American Academy of Physical Medicine and Rehabilitation.
    Fugate LP; Spacek LA; Kresty LA; Levy CE; Johnson JC; Mysiw WJ
    Arch Phys Med Rehabil; 1997 Sep; 78(9):924-8. PubMed ID: 9305262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Use of Atypical Antipsychotics for Managing Agitation After Traumatic Brain Injury.
    McKay A; Trevena-Peters J; Ponsford J
    J Head Trauma Rehabil; 2021 May-Jun 01; 36(3):149-155. PubMed ID: 32898031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of agitation following traumatic brain injury: a review of the literature.
    Levy M; Berson A; Cook T; Bollegala N; Seto E; Tursanski S; Kim J; Sockalingam S; Rajput A; Krishnadev N; Feng C; Bhalerao S
    NeuroRehabilitation; 2005; 20(4):279-306. PubMed ID: 16403996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia.
    Mühlbauer V; Möhler R; Dichter MN; Zuidema SU; Köpke S; Luijendijk HJ
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013304. PubMed ID: 34918337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressants for agitation and psychosis in dementia.
    Seitz DP; Adunuri N; Gill SS; Gruneir A; Herrmann N; Rochon P
    Cochrane Database Syst Rev; 2011 Feb; (2):CD008191. PubMed ID: 21328305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haloperidol for agitation in dementia.
    Lonergan E; Luxenberg J; Colford J
    Cochrane Database Syst Rev; 2001; (4):CD002852. PubMed ID: 11687166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.